Resistance to Castration – Resistance to Drugs
作者： Stefania Staibano
DOI: 10.1007/978-94-007-7149-9_7
关键词:
摘要: Up to 70 % of newly diagnosed patients with advanced prostate cancer (PCa) will progress castration-resistant (CRPC) and, in most cases (from 50 %), develop hematogenous bone metastasis. Once PCa cells spread the skeleton, cancer-related death becomes inevitable, a burden more than 28,000 2012, United States (Semenas et al, Curr Drug Target, 13(10):1308–1323, 2012).
core.ac.uk
springer.com
sci-hub.st 参考文章(81)
C D Petraki, C P Sfikas, Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma. Histology and Histopathology. ,vol. 22, pp. 107- 118 ,(2007) , 10.14670/HH-22.107
Laura Díez Sicilia, Alfredo Rodríguez Antolín, José Manuel Duarte Ojeda, Ángeles Cabeza Rodríguez, Rafael Díaz González, Mario Domínguez Esteban, Daniel Castellano, J. Romero Otero, Hormonal treatment in biochemical recurrence after radical prostatectomy Archivos españoles de urología. ,vol. 65, pp. 111- 121 ,(2012)
Niall M Corcoran, Martin E Gleave, Targeted therapy in prostate cancer. Histopathology. ,vol. 60, pp. 216- 231 ,(2012) , 10.1111/J.1365-2559.2011.04030.X
H I Scher, C Liebertz, W K Kelly, M Mazumdar, C Brett, L Schwartz, G Kolvenbag, L Shapiro, M Schwartz, Bicalutamide for advanced prostate cancer: the natural versus treated history of disease Journal of Clinical Oncology. ,vol. 15, pp. 2928- 2938 ,(1997) , 10.1200/JCO.1997.15.8.2928
Tobias Zellweger, Hideaki Miyake, Laura V. July, Majid Akbari, Satoshi Kiyama, Martin E. Gleave, Chemosensitization of Human Renal Cell Cancer Using Antisense Oligonucleotides Targeting the Antiapoptotic Gene Clusterin Neoplasia. ,vol. 3, pp. 360- 367 ,(2001) , 10.1038/SJ.NEO.7900174
Deborah A. Bradley, Maha Hussain, Promising novel cytotoxic agents and combinations in metastatic prostate cancer. Cancer Journal. ,vol. 14, pp. 15- 19 ,(2008) , 10.1097/PPO.0B013E31816220B7
Martin J. Bullock, John R. Srigley, Lawrence H. Klotz, S. Larry Goldenberg, Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial. The American Journal of Surgical Pathology. ,vol. 26, pp. 1400- 1413 ,(2002) , 10.1097/00000478-200211000-00002
Li-Fen Lee, Maggie C Louie, Sonal J Desai, Joy Yang, Hong-Wu Chen, Christopher P Evans, Hsing-Jien Kung, Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK Oncogene. ,vol. 23, pp. 2197- 2205 ,(2004) , 10.1038/SJ.ONC.1207344
Álvaro Pinto, María Merino, Pilar Zamora, Andrés Redondo, Beatriz Castelo, Enrique Espinosa, Targeting the endothelin axis in prostate carcinoma. Tumor Biology. ,vol. 33, pp. 421- 426 ,(2012) , 10.1007/S13277-011-0299-6
E. Tiligada, V. Miligkos, A. Delitheos, Cross-talk between Cellular Stress, Cell Cycle and Anticancer Agents: Mechanistic Aspects Current Medicinal Chemistry - Anti-cancer Agents. ,vol. 2, pp. 553- 566 ,(2002) , 10.2174/1568011023353976